Cardiovascular Consequences of Inhaled Short-acting Beta-agonist Use
Clinical trial NCT06027606 · COMPLETED
Trial details
- NCT number
- NCT06027606
- Sponsor
- University of Alberta
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2025-09-25
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.